Cargando…
Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosis
Tuberculosis (TB) causes 1.6 million deaths annually. Early differential diagnosis of active TB infection is essential in optimizing treatment and reducing TB mortality, but is hampered by a lack of accurate and accessible diagnostics. Previously, we reported on complement component C1q, measured in...
Autores principales: | Dijkman, Karin, Lubbers, Rosalie, Borggreven, Nicole V., Ottenhoff, Tom H. M., Joosten, Simone A., Trouw, Leendert A., Verreck, Frank A. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156429/ https://www.ncbi.nlm.nih.gov/pubmed/32286384 http://dx.doi.org/10.1038/s41598-020-63041-4 |
Ejemplares similares
-
Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis
por: Lubbers, Rosalie, et al.
Publicado: (2018) -
Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q
por: Niewold, Paula, et al.
Publicado: (2023) -
An imaging mass cytometry immunophenotyping panel for non-human primate tissues
por: Niewold, Paula, et al.
Publicado: (2022) -
Inverse correlation between serum complement component C1q levels and whole blood type‐1 interferon signature in active tuberculosis and QuantiFERON‐positive uveitis: implications for diagnosis
por: Schrijver, Benjamin, et al.
Publicado: (2020) -
Tuberculosis Biomarkers: From Diagnosis to Protection
por: Goletti, Delia, et al.
Publicado: (2016)